BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21716123)

  • 1. How patients view probiotics: findings from a multicenter study of patients with inflammatory bowel disease and irritable bowel syndrome.
    Mercer M; Brinich MA; Geller G; Harrison K; Highland J; James K; Marshall P; McCormick JB; Tilburt J; Achkar JP; Farrell RM; Sharp RR
    J Clin Gastroenterol; 2012 Feb; 46(2):138-44. PubMed ID: 21716123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotics in luminal gastroenterology: the current state of play.
    Andrews JM; Tan M
    Intern Med J; 2012 Dec; 42(12):1287-91. PubMed ID: 23252997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experiences of patients with chronic gastrointestinal conditions: in their own words.
    McCormick JB; Hammer RR; Farrell RM; Geller G; James KM; Loftus EV; Mercer MB; Tilburt JC; Sharp RR
    Health Qual Life Outcomes; 2012 Mar; 10():25. PubMed ID: 22401607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions of gastroenterologists and patients regarding irritable bowel syndrome and inflammatory bowel disease.
    Levy S; Segev M; Reicher-Atir R; Steinmetz A; Horev N; Niv Y; Dickman R
    Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):40-6. PubMed ID: 24025978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics in irritable bowel syndrome and inflammatory bowel disease: review of mechanisms and effectiveness.
    So D; Quigley EMM; Whelan K
    Curr Opin Gastroenterol; 2023 Mar; 39(2):103-109. PubMed ID: 36821458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EHealth: self-management in inflammatory bowel disease and in irritable bowel syndrome using novel constant-care web applications. EHealth by constant-care in IBD and IBS.
    Pedersen N
    Dan Med J; 2015 Dec; 62(12):B5168. PubMed ID: 26621403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side Effects Associated with Probiotic Use in Adult Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Dore MP; Bibbò S; Fresi G; Bassotti G; Pes GM
    Nutrients; 2019 Dec; 11(12):. PubMed ID: 31810233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manipulation of the microbiota for treatment of IBS and IBD-challenges and controversies.
    Shanahan F; Quigley EM
    Gastroenterology; 2014 May; 146(6):1554-63. PubMed ID: 24486051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)-A Critical Review.
    Jakubczyk D; Leszczyńska K; Górska S
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32630805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of probiotics in IBD and IBS.
    De Greef E; Vandenplas Y; Hauser B; Devreker T; Veereman G
    Minerva Pediatr; 2014 Oct; 66(5):491-500. PubMed ID: 25243502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
    Seksik P; Dray X; Sokol H; Marteau P
    Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usefulness of probiotics in inflammatory bowel diseases.
    Mach T
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():23-33. PubMed ID: 17242485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
    Didari T; Mozaffari S; Nikfar S; Abdollahi M
    World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is probiotic use beneficial for skin lesions in patients with inflammatory bowel disease?
    Satta R; Pes GM; Rocchi C; Pes MC; Dore MP
    J Dermatolog Treat; 2019 Sep; 30(6):612-616. PubMed ID: 30244616
    [No Abstract]   [Full Text] [Related]  

  • 15. Diet therapy for inflammatory bowel diseases: The established and the new.
    Durchschein F; Petritsch W; Hammer HF
    World J Gastroenterol; 2016 Feb; 22(7):2179-94. PubMed ID: 26900283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease.
    Whelan K; Quigley EM
    Curr Opin Gastroenterol; 2013 Mar; 29(2):184-9. PubMed ID: 23286925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotic and prebiotic use in patients with inflammatory bowel disease: a case-control study.
    Hedin CR; Mullard M; Sharratt E; Jansen C; Sanderson JD; Shirlaw P; Howe LC; Djemal S; Stagg AJ; Lindsay JO; Whelan K
    Inflamm Bowel Dis; 2010 Dec; 16(12):2099-108. PubMed ID: 20848469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics in the treatment of human inflammatory bowel diseases: update 2011.
    Meijer BJ; Dieleman LA
    J Clin Gastroenterol; 2011 Nov; 45 Suppl():S139-44. PubMed ID: 21992953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance and needs of irritable bowel syndrome (IBS): Comparison with inflammatory bowel disease (IBD). (Please, if you are not interested in IBS, read it.).
    Mearin F; Sans M; Balboa A
    Gastroenterol Hepatol; 2022 Dec; 45(10):789-798. PubMed ID: 35051542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of probiotics in inflammatory bowel disease.
    Cain AM; Karpa KD
    Altern Ther Health Med; 2011; 17(1):72-9. PubMed ID: 21614946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.